市場調查報告書
商品編碼
978913

神經調節的全球市場:2027年前的預測 - COVID-19的影響,技術(外部神經調節,內部神經調節),用途,終端用戶,各地區的分析

Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (External Neuromodulation, and Internal Neuromodulation); Application ; End User, and Geography

出版日期: | 出版商: The Insight Partners | 英文 195 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球神經調節的市場規模在2019年估算為76億1,345萬美金。該市場在2020年∼2027年間預測將以10.3%的年複合成長率增長,2027年達到163億3,398萬美元。市場成長的主要因素有神經病的發病率增加和神經調節技術的發展。然而,神經調節裝置的高成本阻礙了市場的增長。

本報告提供全球神經調節市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,COVID-19疫情的影響,技術·用途·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 要點

第3章 調查手法

第4章 市場形勢

  • 概要
  • PEST分析
  • 專家的見解

第5章 主要市場動態

  • 市場成長要素
  • 市場阻礙因素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 市場收益預測與分析
  • 各地區:市場預測與分析
  • 主要企業的市場上地位

第7章 市場分析:各技術

  • 概要
  • 市場佔有率(2019,2027)
  • 外部神經調節
  • 內部神經調節

第8章 市場分析:各用途

  • 概要
  • 市場佔有率(2019,2027)
  • 慢性疼痛管理
  • 失敗症候群
  • 癲癇
  • 震顫
  • 失禁
  • 憂鬱症
  • 肌張力不全症
  • 胃輕癱
  • 帕金森氏症
  • 強迫性精神官能症(OCD)
  • 偏頭痛

第9章 市場分析:各終端用戶

  • 概要
  • 市場佔有率(2019,2027)
  • 醫院
  • 診所
  • 家庭醫療保健

第10章 市場分析:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 中南美

第11章 COVID-19疫情對市場帶來的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第12章 產業形勢

  • 概要
  • 市場企業的成長策略
  • 有機開發
  • 無機開發

第13章 企業簡介

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim

第14章 附錄

  • 詞彙表
目錄
Product Code: TIPHE100001415

The Neuromodulation market was valued at US$ 7,613.45 million in 2019 and is projected to reach US$ 16,333.98 million by 2027; it is expected to grow at a CAGR of 10.3% during 2020-2027. The growth of the market is attributed to increasing incidence of neurological disorders and growing developments in neuromodulation technology. However, the high cost of neuromodulation devices hinders the growth of the market .

Neuromodulators alter the nerve activity by delivering electrical or pharmaceutical agents precisely at the target site. These are frequently used for chronic pain relief. The growing technological advancements in neuromodulation have increased its applications. For instance, deep brain stimulation (DBS) is used for treating Parkinson's disease, sacral nerve stimulation for resolving pelvic disorders and urinary incontinence, and spinal cord stimulation for addressing ischemic disorders such as angina and peripheral vascular disease. Companies operating in the neuromodulation market are receiving FDA approvals for their innovative products and raising funds for product development, which, in turn, propels the growth of the market .

On the basis of technology, the global neuromodulation market is bifurcated into external (non-invasive) neuromodulation and internal neuromodulation. The external (non-invasive) neuromodulation segment held a larger share of the market in 2019, and it is expected to register a higher CAGR during the forecast period.Based on application, the global neuromodulation market is segmented into chronic pain management, failed back syndrome, epilepsy, tremor, incontinence, depression, dystonia, gastroparesis, Parkinson's disease, obsessive-compulsive disorder, and migraine. The chronic pain management segment held the largest share of the market in 2019, and the same segment is expected to register the highest CAGR during the forecast period.

Food Safety and Inspection Service(FSIS), US Food and Drug Administration (FDA), National Institute of Health (NIH),National Health Agency (ANVISA), European Medical Association, and Asia-Pacific Centre for Neuromodulation (APCN)are a few of the secondary sources referred for preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the neuromodulation market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Neuromodulation Market - By Technology
    • 1.3.2 Neuromodulation Market - By Application
    • 1.3.3 Neuromodulation Market - By End User
    • 1.3.4 Global Neuromodulation Market - By Geography

2. Neuromodulation Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Neuromodulation- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. Neuromodulation Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Neurological Disorders
    • 5.1.2 Growing Developments in Neuromodulation Technology
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Neuromodulation Devices
  • 5.3 Market Opportunities
    • 5.3.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements
  • 5.5 Impact Analysis

6. Neuromodulation Market- Global Analysis

  • 6.1 Global Neuromodulation Market Revenue Forecast and Analysis
  • 6.2 Global Neuromodulation Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Neuromodulation Market Analysis - By Technology

  • 7.1 Overview
  • 7.2 Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
  • 7.3 External Neuromodulation
    • 7.3.1 Overview
    • 7.3.2 External Neuromodulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.3.3 Respiratory Electrical Stimulation (RES)
      • 7.3.3.1 Overview
      • 7.3.3.2 Respiratory Electrical Stimulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 7.3.4.1 Overview
      • 7.3.4.2 Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.3.5 Transcranial Magnetic Stimulation (TMS)
      • 7.3.5.1 Overview
      • 7.3.5.2 Transcranial Magnetic Stimulation (TMS): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Internal Neuromodulation
    • 7.4.1 Overview
    • 7.4.2 Internal Neuromodulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.3 Deep Brain Stimulation (DBS)
      • 7.4.3.1 Overview
      • 7.4.3.2 Deep Brain Stimulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.4 Sacral Nerve Stimulation (DBS)
      • 7.4.4.1 Overview
      • 7.4.4.2 Sacral Nerve Stimulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.5 Gastric Electric Stimulation (GES)
      • 7.4.5.1 Overview
      • 7.4.5.2 Gastric Electric Stimulation (GES): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.6 Spinal Cord Stimulation (SCS)
      • 7.4.6.1 Overview
      • 7.4.6.2 Spinal Cord Stimulation (SCS): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
    • 7.4.7 Vagus Nerve Stimulation (VNS)
      • 7.4.7.1 Overview
      • 7.4.7.2 Vagus Nerve Stimulation (VNS): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)

8. Neuromodulation Market Analysis - By Application

  • 8.1 Overview
  • 8.2 Neuromodulation Market Share, by Application, 2019 and 2027 (%)
  • 8.3 Chronic Pain Management
    • 8.3.1 Overview
    • 8.3.2 Chronic Pain Management: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Failed Back Syndrome
    • 8.4.1 Overview
    • 8.4.2 Failed Back Syndrome: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Epilepsy
    • 8.5.1 Overview
    • 8.5.2 Epilepsy: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Tremor
    • 8.6.1 Overview
    • 8.6.2 Tremor: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • 8.7 Incontinence
    • 8.7.1 Overview
    • 8.7.2 Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.8 Depression
    • 8.8.1 Overview
    • 8.8.2 Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.9 Dystonia
    • 8.9.1 Overview
    • 8.9.2 Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.10 Gastroparesis
    • 8.10.1 Overview
    • 8.10.2 Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.11 Parkinson's Disease
    • 8.11.1 Overview
    • 8.11.2 Parkinson's Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.12 Obsessive-Compulsive Disorder (OCD)
    • 8.12.1 Overview
    • 8.12.2 Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.13 Migraine
    • 8.13.1 Overview
    • 8.13.2 Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

9. Neuromodulation Market Analysis - By End User

  • 9.1 Overview
  • 9.2 Neuromodulation Market Share, by End User, 2019 and 2027, (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Clinics
    • 9.4.1 Overview
    • 9.4.2 Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Home Healthcare
    • 9.5.1 Overview
    • 9.5.2 Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)

10. Neuromodulation Market Analysis and Forecasts To 2027 - Geographical Analysis

  • 10.1 North America: Neuromodulation Market
    • 10.1.1 Overview
    • 10.1.2 North America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 North America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.1 North America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.2 North America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 North America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 North America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 North America: Neuromodulation Market, by Country, 2019 & 2027 (%)
    • 10.1.7 US: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 US: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 US: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.1.7.2.1 US: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.7.2.2 US: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 US: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 US: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Canada: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Canada: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Canada: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.1.8.2.1 Canada: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.8.2.2 Canada: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Canada: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Canada: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 Mexico: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 Mexico: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 Mexico: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.1.9.2.1 Mexico: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.1.9.2.2 Mexico: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 Mexico: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 Mexico: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.2 Europe: Neuromodulation Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
    • 10.2.3 Europe: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.2.3.1 Europe: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.3.2 Europe: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.2.4 Europe: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.2.5 Europe: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.6 Europe: Neuromodulation Market, by Country, 2019 & 2027 (%)
    • 10.2.7 Germany: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.1 Germany: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.2 Germany: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.2.7.2.1 Germany: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.7.2.2 Germany: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.3 Germany: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.2.7.4 Germany: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.8 UK: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.1 UK: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.2 UK: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.2.8.2.1 UK: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.8.2.2 UK: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.3 UK: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.2.8.4 UK: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.9 France: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.1 France: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.2 France: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.2.9.2.1 France: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.9.2.2 France: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.3 France: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.2.9.4 France: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.10 Spain: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.1 Spain: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.2 Spain: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.2.10.2.1 Spain: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.10.2.2 Spain: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.3 Spain: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.2.10.4 Spain: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.2.11 Italy: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.1 Italy: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.2 Italy: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.2.11.2.1 Italy: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.2.11.2.2 Italy: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.3 Italy: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.2.11.4 Italy: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.3 Asia Pacific: Neuromodulation Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
    • 10.3.3 Asia Pacific: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.3.3.1 Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.3.2 Asia Pacific: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.3.4 Asia Pacific: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.3.5 Asia Pacific: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.6 Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)
    • 10.3.7 China: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.1 China: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.2 China: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.3.7.2.1 China: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.7.2.2 China: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.3 China: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.3.7.4 China: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.8 Japan: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.1 Japan: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.2 Japan: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.3.8.2.1 Japan: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.8.2.2 Japan: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.3 Japan: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.3.8.4 Japan: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.9 India: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.1 India: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.2 India: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.3.9.2.1 India: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.9.2.2 India: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.3 India: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.3.9.4 India: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.10 South Korea: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.1 South Korea: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.2 South Korea: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.3.10.2.1 South Korea: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.10.2.2 South Korea: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.3 South Korea: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.3.10.4 South Korea: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.3.11 Australia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.1 Australia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.2 Australia: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.3.11.2.1 Australia: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.3.11.2.2 Australia: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.3 Australia: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.3.11.4 Australia: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.4 Middle East and Africa: Neuromodulation Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
    • 10.4.3 Middle East and Africa: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.4.3.1 Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.3.2 Middle East and Africa: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.4.4 Middle East and Africa: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.4.5 Middle East and Africa: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.6 Middle East and Africa: Neuromodulation Market, by Country, 2019 & 2027 (%)
    • 10.4.7 Saudi Arabia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.1 Saudi Arabia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.2 Saudi Arabia: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.4.7.2.1 Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.7.2.2 Saudi Arabia: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.3 Saudi Arabia: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.4.7.4 Saudi Arabia: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.8 UAE: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.1 UAE: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.2 UAE: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.4.8.2.1 UAE: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.8.2.2 UAE: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.3 UAE: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.4.8.4 UAE: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.4.9 South Africa: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.1 South Africa: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.2 South Africa: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.4.9.2.1 South Africa: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.4.9.2.2 South Africa: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.3 South Africa: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.4.9.4 South Africa: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 10.5 South and Central America: Neuromodulation Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)
    • 10.5.3 South and Central America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.5.3.1 South and Central America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.3.2 South and Central America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
    • 10.5.4 South and Central America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.5.5 South and Central America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.5.6 South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)
    • 10.5.7 Brazil: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.1 Brazil: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.2 Brazil: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.5.7.2.1 Brazil: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.5.7.2.2 Brazil: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.3 Brazil: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.5.7.4 Brazil: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 10.5.8 Argentina: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.1 Argentina: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.2 Argentina: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
        • 10.5.8.2.1 Argentina: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
        • 10.5.8.2.2 Argentina: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.3 Argentina: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
      • 10.5.8.4 Argentina: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on Global Neuromodulation Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Neuromodulation Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Boston Scientific Corporation
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Medtronic
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 NeuroPace, Inc.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 NeuroSigma, Inc.
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 NEVRO CORP.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Synapse Biomedical Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Soterix Medical Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Integer Holdings Corporation
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Magstim
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 Glossary of Terms

List Of Tables

  • Table 1. North America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 5. North America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 9. US: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 10. US: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Canada: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Canada: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Canada: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Mexico: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Mexico: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Mexico: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Mexico: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Mexico: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Europe: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Europe: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Europe: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 24. Europe: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Europe: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Germany: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Germany: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Germany: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 29. Germany: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 30. Germany: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 31. UK: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 32. UK: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 33. UK: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 34. UK: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 35. UK: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 36. France: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 37. France: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 38. France: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. France: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 40. France: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Spain: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Spain: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Spain: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Spain: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Spain: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Italy: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Italy: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 48. Italy: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Italy: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Italy: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Asia Pacific: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Asia Pacific: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 54. Asia Pacific: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Asia Pacific: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 56. China: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 57. China: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 58. China: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 59. China: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 60. China: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 61. Japan: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 62. Japan: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Japan: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Japan: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Japan: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 66. India: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 67. India: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 68. India: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 69. India: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 70. India: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 71. South Korea: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 72. South Korea: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 73. South Korea: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 74. South Korea: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 75. South Korea: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 76. Australia: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 77. Australia: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 78. Australia: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 79. Australia: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 80. Australia: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 81. Middle East and Africa: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 82. Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 83. Middle East and Africa: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 84. Middle East and Africa: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 85. Middle East and Africa: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 86. Saudi Arabia: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 87. Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 88. Saudi Arabia: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 89. Saudi Arabia: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 90. Saudi Arabia: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 91. UAE: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 92. UAE: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 93. UAE: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 94. UAE: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 95. UAE: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 96. South Africa: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 97. South Africa: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 98. South Africa: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 99. South Africa: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 100. South Africa: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 101. South and Central America: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 102. South and Central America: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 103. South and Central America: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 104. South and Central America: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 105. South and Central America: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 106. Brazil: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 107. Brazil: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 108. Brazil: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 109. Brazil: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 110. Brazil: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 111. Argentina: Neuromodulation Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 112. Argentina: External (Non-Invasive) Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 113. Argentina: Internal Neuromodulation Market, by Type - Revenue and Forecast to 2027 (USD Million)
  • Table 114. Argentina: Neuromodulation Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 115. Argentina: Neuromodulation Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 116. Organic Developments Done by Companies
  • Table 117. Inorganic Developments Done by Companies
  • Table 118. Glossary of Terms, Neuromodulation Market

List Of Figures

  • Figure 1. Neuromodulation Market Segmentation
  • Figure 2. Neuromodulation Market - By Geography
  • Figure 3. Global Neuromodulation Market Overview
  • Figure 4. Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Neuromodulation Market, By Geography (US$ Million)
  • Figure 7. Global Neuromodulation Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Neuromodulation Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. Neuromodulation Market Impact Analysis of Drivers and Restraint
  • Figure 15. Global Neuromodulation Market- Revenue Forecast and Analysis - 2019- 2027
  • Figure 16. Global Neuromodulation Market- By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning of Key Players in Global Neuromodulation Market
  • Figure 18. Neuromodulation Market Share, by Technology, 2019 and 2027 (%)
  • Figure 19. External Neuromodulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Respiratory Electrical Stimulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Transcranial Magnetic Stimulation (TMS): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Internal Neuromodulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Deep Brain Stimulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Sacral Nerve Stimulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Gastric Electric Stimulation: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Spinal Cord Stimulation (SCS): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Vagus Nerve Stimulation (VNS): Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Neuromodulation Market Share, by Application, 2019 and 2027 (%)
  • Figure 30. Chronic Pain Management: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Failed Back Syndrome: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Epilepsy: Neuromodulation Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Tremor: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. Incontinence: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 35. Depression: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 36. Dystonia: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 37. Gastroparesis: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 38. Parkinson's Disease: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 39. Obsessive-Compulsive Disorder: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 40. Migraine: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 41. Neuromodulation Market Share, by End User, 2019 and 2027 (%)
  • Figure 42. Hospitals Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 43. Clinics: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 44. Home Healthcare: Neuromodulation Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 45. North America: Neuromodulation Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. North America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 47. North America: Neuromodulation Market, by Country, 2019 & 2027 (%)
  • Figure 48. US: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Canada: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Mexico: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Europe: Neuromodulation Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 52. Europe: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Europe: Neuromodulation Market, by Country, 2019 & 2027 (%)
  • Figure 54. Germany: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. UK: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. France: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Spain: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 58. Italy: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Asia Pacific: Neuromodulation Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 60. Asia Pacific: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 61. Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)
  • Figure 62. China: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. Japan: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 64. India: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. South Korea: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Australia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. Middle East and Africa: Neuromodulation Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 68. Middle East and Africa: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 69. Middle East and Africa: Neuromodulation Market, by Country, 2019 & 2027 (%)
  • Figure 70. Saudi Arabia: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 71. UAE: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 72. South Africa: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 73. South and Central America: Neuromodulation Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 74. South and Central America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 75. South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)
  • Figure 76. Brazil: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 77. Argentina: Neuromodulation Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 78. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 79. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 80. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 81. Impact of COVID-19 Pandemic in Rest of the World Country Market
  • Figure 82. Growth Strategies Done by the Companies in the Market, (%)